Article ; Online: Cibler la protéase majeure du SARS-CoV-2 pour fabriquer un médicament efficace contre ce coronavirus.
2020 Volume 36, Issue 6-7, Page(s) 555–558
Title translation | SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19. |
---|---|
MeSH term(s) | Antiviral Agents/therapeutic use ; Betacoronavirus/enzymology ; Betacoronavirus/physiology ; COVID-19 ; Coronavirus Infections/drug therapy ; Coronavirus Infections/epidemiology ; Coronavirus Infections/prevention & control ; HIV Protease Inhibitors/therapeutic use ; Humans ; Pandemics/prevention & control ; Peptide Hydrolases/physiology ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/prevention & control ; Protease Inhibitors/therapeutic use ; SARS-CoV-2 ; Virus Replication |
Chemical Substances | Antiviral Agents ; HIV Protease Inhibitors ; Protease Inhibitors ; Peptide Hydrolases (EC 3.4.-) |
Keywords | covid19 |
Language | French |
Publishing date | 2020-06-19 |
Publishing country | France |
Document type | News |
ZDB-ID | 632733-3 |
ISSN | 1958-5381 ; 0767-0974 |
ISSN (online) | 1958-5381 |
ISSN | 0767-0974 |
DOI | 10.1051/medsci/2020106 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 2872: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.